Professor David Maintz

University Hospital Cologne, Department of Radiology

A clinical, research and exam board career spanning 22+ years in both USA and Germany has led me to my current role as the Director, Department of Radiology at the University of Cologne. Our department is one of the Iargest academic radiology institutions in Germany, equipped with the latest technologies. In May 2016, the first IQon in Germany was installed in Cologne. Since then we have delivered a large number of publications on that topic. Other research topics of our department are oncologic and cardiac imaging, image guided interventions and artificial intelligence in radiology.

dont miss

Spectral CT: Dual layer technology helps to increase diagnostic confidence

This talk will report on the two year experience with the new dual layer spectral CT. Several studies have given scientific proof that image quality improvement can be achieved that helps to
detect and characterize pathologic lesions in different parts of the body, hereby increasing diagnostic confidence. At the same time, radiation and contrast media dose may be reduced.

EVEN MORE SEMINARS

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Dr Christy Goldsmith: Speaking at the Oncology Convention

    Dr Christy Goldsmith
    Action Radiotherapy

    Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)

  • Dr Ndaba Mazibuko: Speaking at the Oncology Convention

    Dr Ndaba Mazibuko
    Care Oncology Clinic, Kings College London

    Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management

  • Michiel van den Brekel: Speaking at the Oncology Convention

    Michiel van den Brekel
    The Netherlands Cancer Institute

    Vocal and pulmonary rehabilitation after total laryngectomy

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy